CNR Institutional Research Information System

POCHETTI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.586
NA - Nord America 1.007
SA - Sud America 316
EU - Europa 289
AF - Africa 28
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 960
SG - Singapore 682
CN - Cina 343
BR - Brasile 257
VN - Vietnam 179
HK - Hong Kong 165
FR - Francia 91
KR - Corea 77
IT - Italia 48
NL - Olanda 36
BD - Bangladesh 27
AR - Argentina 26
IN - India 26
FI - Finlandia 25
GB - Regno Unito 24
CA - Canada 18
JP - Giappone 18
DE - Germania 17
ID - Indonesia 17
EC - Ecuador 10
IQ - Iraq 10
MX - Messico 10
PL - Polonia 7
ZA - Sudafrica 7
CO - Colombia 6
EG - Egitto 6
IL - Israele 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
PT - Portogallo 5
VE - Venezuela 5
AT - Austria 4
CL - Cile 4
KE - Kenya 4
MA - Marocco 4
RU - Federazione Russa 4
UA - Ucraina 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
SE - Svezia 3
CZ - Repubblica Ceca 2
ES - Italia 2
KG - Kirghizistan 2
MY - Malesia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 3.229
Salva come PNG Salva come JPEG
Città #
Santa Clara 478
Singapore 406
Hefei 163
Hong Kong 160
Lauterbourg 80
San Jose 80
Seoul 77
Ho Chi Minh City 64
Ashburn 59
Beijing 52
Hanoi 51
Los Angeles 27
São Paulo 20
Chicago 15
Dallas 14
Buffalo 12
Da Nang 12
Helsinki 11
New York 10
Rio de Janeiro 9
Tokyo 9
Frankfurt am Main 8
Turku 8
Minamishinagawa 7
Belo Horizonte 6
Haiphong 6
Lappeenranta 6
Milan 6
Rome 6
Chennai 5
Guayaquil 5
Manchester 5
Mumbai 5
Warsaw 5
Atlanta 4
Blumenau 4
Bogotá 4
Brasília 4
Brooklyn 4
Buenos Aires 4
Campinas 4
Curitiba 4
Houston 4
Johannesburg 4
London 4
Montreal 4
Nairobi 4
Ninh Bình 4
Orem 4
Quito 4
Thái Bình 4
Amsterdam 3
Biên Hòa 3
Bom Despacho 3
Boston 3
Caxias do Sul 3
Corrientes 3
Delhi 3
Dhaka 3
Dubai 3
Düsseldorf 3
Fortaleza 3
Greenville 3
Guarulhos 3
Hamilton 3
Hortolândia 3
Hải Dương 3
Jakarta 3
Joinville 3
Juiz de Fora 3
Lima 3
Maceió 3
Minneapolis 3
Modena 3
Poplar 3
Porto Alegre 3
Raleigh 3
San José 3
Shanghai 3
Stockholm 3
Tampa 3
The Bronx 3
The Dalles 3
Thái Nguyên 3
Tirana 3
Albuquerque 2
Baghdad 2
Bahía Blanca 2
Ballston Spa 2
Bengaluru 2
Berkeley 2
Bishkek 2
Boardman 2
Campos dos Goytacazes 2
Can Tho 2
Casablanca 2
Chesterfield 2
Covington 2
Dublin 2
Fargo 2
Totale 2.087
Salva come PNG Salva come JPEG
Nome #
Resveratrol and Its Metabolites Bind to PPARs 98
Insights into PPARgamma Phosphorylation and Its Inhibition Mechanism 97
Pha-680626 is an effective inhibitor of the interaction between aurora-a and n-myc 75
Regulation of gene expression in the liver and adipose tissue by a new dual PPARalpha/gamma agonist 72
On the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 71
Conformational studies of synthetic leucinostatin A fragments 67
Screening of saponins and sapogenins from Medicago species as potential PPAR? agonists and X-ray structure of the complex PPAR?/caulophyllogenin 67
Discovery of novel chemical series of oxa-48 beta-lactamase inhibitors by high-throughput screening 67
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 66
Crystal Structures of the Complexes between PPARgamma and two new ligands with dual activity 65
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex 65
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 63
Water induced beta-turn modification in a chemotactic tetrapeptide. Synthesis, crystal conformation, and activity of HCO-Met-Leu-DeltaZPhe-Phe-OMe 59
Betulinic acid is a PPARg antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis 56
On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator-Activated Receptors and Skeletal Muscles. 56
Structural Insight into Peroxisome Proliferator-Activated Receptor ³ Binding of Two Ureidofibrate-Like Enantiomers by Molecular Dynamics, Cofactor Interaction Analysis, and Site-Directed Mutagenesis 55
Conformationally constrained analogues of endogenous tripeptide inhibitors of zinc metalloproteinases. 55
Structural basis of the transactivation deficiency of the human PPAR gamma F360L mutant associated with familial partial lipodystrophy 55
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor gamma Binding Properties and Biological Activities 54
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 53
Metalloproteinase Inhibitors, their Therapeutic Use and Process for the Production of the Starting Compound in the Synthesis Thereof 47
Design and biophysical characterization of atrazine-sensing peptides mimicking the Chlamydomonas reinhardtii plastoquinone binding niche. 47
LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties 47
Identification of the first PPARa/g able to bind to canonical and alternate sites of PPARg and to inhibit its Cdk-5-mediated phosphorylation 46
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode. 45
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists able ti up regulate the mitochondrial carnitine shuttle system gene expression. 44
Inhibitors of Metalloproteinase, their Therapeutic Use, and Process for the Production of the Starting Compound in the Synthesis 43
Crystal Structure of PPARgamma Ligand Binding Domain complexed with a novel Partial Agonist: a new region of the hydrophobic pocket could be exploited for drug design 43
Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors alpha and gamma for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection 41
Affinity-Based Separation Methods for the Study of Biological Interactions: the case of Peroxisome Proliferator-Activated Receptors in drug discovery 38
The monoclinic phase of the 2/1 inclusion compound between deoxycholic acid and o-xylene 38
Crystal structure of the PPAR-gamma ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design 37
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. 32
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 32
Structure and conformation of peptides containing the sulphonamide junction. I. N-acetyl-tauryl-L-phenylalanine methyl ester. 31
Frontal affinity chromatography with MS detection of the ligand binding domain of PPARg receptor: Ligand affinity screening and stereoselective ligand-macromolecule interaction. 30
Gamma-Turn Conformation Induced by ,-Disubstituted Amino Acids with a Cyclic Six-Membered Side Chain 30
2 Angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode 29
Structure of a triclinic phase of sodium dodecyl sulfate monohydrate. A comparison with other sodium dodecyl sulfate crystal phases 29
Computational study of the catalytic domain of human neutrophil collagenase. Specific role of the S3 and S3' subsites in the interaction with a phosphonate inhibitor 29
Structural studies of a human chimeric plasminogen activator Amediplase (k2tu-PA) 29
Topographically constrained aromatic-alpha-aza-amino acids. Synthesis, molecular structure, and conformation of two azaTic derivatives 28
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 28
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor-gamma ligand-binding domain in the complex with two enantiomeric ligands 28
SYNTHESIS, Characterization and biological evaluation of ureidofibrate-like derivatives endowed with Peroxisome Proliferator-Activated Receptor Activity 28
Structure and conformation of peptides containing the sulphonamide junction. IV. Synthesis and crystal conformation of N-benzoyl-L-Phenylalanyl-Tauryl-L-Leucine Methyl Ester 27
Structure of the 4:1 inclusion compound between deoxycholic acid and (E)-p-dimethylaminobenzene 27
Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides. 27
Peptides containing the sulfonamide junction: synthesis, structure, and conformation of Z-Tau-Pro-Phe-NHiPr 26
Molecular organization of sodium dodecylsulfate in crystal phases 26
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors alpha/gamma Dual Agonists with Improved Potency and Reduced Adverse Effects on skeletal muscle function 26
Structural studies of Leucinostatin A and its Boc-Aib-Leu-Leu-Aib-OMe tetra peptide fragment 26
Internal .beta.-Turn Hydration: Crystallographic Evidence and Molecular Dynamics Simulation 26
Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design. 25
Identification of novel dual peroxisome proliferator-activated receptor alpha/gamma ligands and characterization of their biochemical properties by 3D structural studies 25
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 25
Studies on the activity of a new ligand of the peroxisome proliferator-activated receptors (PPARs) 25
For-Met-DeltazLeu-Phe-OMe: A new active analog of chemotactic N-formyltripeptides with beta-turn crystal conformation 25
Partial agonism in PPARs: the role of helix 3 24
A reinvestigation of the reaction of N-(2-bromoethyl)isatoic anhydride with methyl amine. Isolation and crystal structure of 1-(2-hydroxyethyl)-3-methyl-2,4-(1H,3H)-Quinazolinedione 24
Improved lipid metabolism and reduced fat deposition in a mouse model of diet-induced obesity (DIO) with a new dual PPARalpha/gamma ligand 24
Structure and conformation of peptides containing the sulphonamide junction. III. Synthesis, crystal and molecular structure of a taurine containing peptidic oxa-cyclol. 24
Retrosulfonamido peptide analogues. Synthesis and crystal conformation of Boc-Pro-Leu-psi(NH-SO2)-Gly-NH2 24
Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe. 24
Structural studies of chemotactic oligopeptides. Crystal, molecular structure and energy calculations of N-Formyl-Methionyl-Leucyl-Phenylalanyl methyl ester 23
Crystal phases obtained from aqueous solutions of sodium dodecyl sulfate. The structure of a monoclinic phase of sodium dodecyl sulfate hemihydrate 23
N-Acyl-diketopiperazines. II. Crystal structure and conformation of N-(pyruvoyl)-cyclo-(L-Phenylalanyl-D-Prolyl) 23
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. 23
Phosphonate inhibitors of adamalysin II and matrix metalloproteinases. 23
Crystal structure, conformation, and potential energy calculations of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OMe. 23
Structural modification and conformational features of chemotactic N-formylpeptides 22
The inclusion compound of deoxycholic acid with (-)-camphor: a structural and energetic study 22
The structure of 2/1 'Channel' Inclusion Compound between Deoxycholic Acid and Pinacolone, 2C24H40O4.C6H12O 22
Inhibition of Adamalysin II and MMPs by phosphonate analogues of snake venom peptides 22
Prochiral selectivity in H2O2-promoted oxidation of arylalkanols catalysed by chloroperoxidase 22
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue 22
Synthesis and structural studies of N-p-Toluensulfonyl cyclodipeptides 21
Structural insight into the crucial role of ligand chirality in the activation of PPARs by crystallographic methods 21
New chemotactic peptide analogs with high biological activity for human neutrophils. 21
Endoannular reactions and ring-chain tautomerism. Structure of 1-(2-Hydroxyethyl)-3-methyl-2,4(1H,3H)-quinazolinedione 21
Stereoselectivity by enantiomeric inhibitors of matrix metalloproteinase-8: new insights from molecular dynamics simulations 21
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe. 21
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli. 21
Novel dual PPARalpha/gamma agonists, as potential hypoglycemic and anti diabetic agents 20
Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe. 20
Potential energy calculations on phenylalanine rotamers in different boat forms of proline-containing cyclic dipeptides. 20
Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues. 19
Structure and conformation of peptides containing the sulfonamide junction. II. Synthesis and conformation of cyclo[-MeTau-Phe-DPro-]. 19
Studies related to cephalosporins. 6(1). Bromination of 3-exomethylene in cepham derivatives 19
On the mechanism of partial agonism: crystal structures of the peroxisome proliferators-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands 18
Synthesis and properties of chemotactic peptide analogs. I. Crystal structure and molecular conformation of HCO-Met-leu-Ain-OMe. 18
Totale 3.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.992
article - articoli 9.155
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 2 0 2 3
2024/20251.295 1 8 78 62 382 107 15 30 38 47 283 244
2025/20261.836 118 179 254 296 319 31 285 101 92 72 38 51
2026/2027127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 3.265